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Background
Mammalian cells are a widely used expression platform
for the production of recombinant therapeutic proteins
or viral particle-based vaccines since they typically per-
form appropriate protein post-translational modifica-
tions and authentic viral particle assembly. Of the
available mammalian cells, HEK 293 is one of the most
industrially relevant cell lines because it is cGMP com-
pliant and is able to grow in suspension in a variety of
commercial serum-free media. Of note, production of
human therapeutics in mammalian cell culture has
become more and more stringent in past recent years
and not only demands serum-free but also animal-com-
ponent free production conditions to ensure safety. This
work is part of a project aimed to optimize HEK 293
cell growth by addition of non-animal derived compo-
nents to serum-free and protein-free media through
design of experiments (DoE) in order to maximize pro-
ductivity of a recombinant VLP vaccine by PEI-mediated
transient transfection.
Materials and methods
The cell line used in this work is a serum-free suspen-
sion-adapted HEK 293 cell line from a cGMP master
cell bank from the Biotechnology Institute of the
National Research Council in Montreal, Canada. Cells
were maintained in exponential growth in 125-mL dis-
posable polycarbonate Erlenmeyer flasks shaken at 110
rpm using an orbital shaker placed in an incubator with
a 37°C, humidified, 5% CO2 atmosphere. Cell count and
viability were determined using trypan blue and a
microscope counting chamber.
Results
We have analyzed the kinetics of HEK 293 cell growth
in HyQ SFM4 Transfx293 from HyClone Thermo Scien-
tific (Logan, UT, USA). The cells grow to a maximum
concentration of ~ 3×106 cells/ml with over 90% viabi-
lity and show an average doubling time of 24 h. In addi-
tion, HEK 293 cell growth was assessed in two other
commercial serum-free culture media, namely ExCell
293 from SAFC Biosciences (Hampshire, UK) and Free-
style 293 from Invitrogen (Carlsbad, CA, USA) both
compatible with PEI-mediated transient transfection ,
showing similar results (Figure 1a). The effect of foetal
bovine sera (FBS) in these serum-free culture media was
also evaluated. Cells can triplicate their maximum cell
densities in the presence of FBS (i.e. they reach 9,3×106
cells/ml in HyQ SFM4 Transfx293 medium + 10% FBS).
Due to the important effect of serum on HEK 293 cell
growth, we decided to evaluate the effect of non-animal
derived serum components on cell growth in attempt to
improve cell densities while keeping animal-origin free
production conditions. For these studies, a pre-defined
mixture of supplements composed of r-albumin (1 g/L),
r-insulin (10 mg/L), r-transferrin (10 mg/L) from Merck
Millipore (Kankakee, IL, USA), and an in-house devel-
oped animal-component free lipid mix (1X) composed
of synthetic cholesterol (SyntheChol®, Sigma-Aldrich,
Steinheim, Germany), fatty acids (F7050, SAFC Bios-
ciences), tocopherol (T1157, Sigma) and emulsifying
agents (PS80, Sigma) at concentrations recommended in
the literature [1] were used. HEK 293 cell density is
improved in the presence of the mix, but only in Free-
style medium a significant difference is observed (Figure
1b). This medium was selected for further optimization
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Figure 1 Optimization of HEK 293 cell growth a) The effect of 10% FBS supplementation in commercially av ailable serum-free media, b) Growth
kinetics of HEK 293 cells in 3 different serum-free protein-free formulations (bI, bII and bIII) in the presence or absence of a pre-defined mixture
of supplements, c) Effect of recombinant proteins or synthetic lipid mix on HEK 293 cell growth, d) Response surface graphs. HEK 293 peak cell
density as a function of the concentrations of Lipid Mix (X) vs. r-Transferrin (mg/L) (dI), r-Transferrin (mg/L) vs. r-Insulin (mg/L) (dII) and Lipid Mix
(X) vs. r-Insulin (mg/L) (dIII) based on Box-Behnken experimental results. Cell density values presented are in millions of cells/mL and represent
mean ± SD (n=3).
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Screening of supplements with significant effect on
HEK 293 cell growth was performed using a Placket-Bur-
man experimental design [2]. Two levels of concentra-
tions were assigned to each variable: a low one with no
additives and a high one based on the typically recom-
mended values mentioned above. Using this strategy, we
were able to determine in 12 experimental runs (per-
formed in duplicate) that r-insulin, r-transferrin and an
in-house developed lipid mix positively affect HEK 293
cell growth in serum-free media formulations, whereas r-
albumin showed no significant effect (Figure 1c).
Optimal concentrations for each supplement showing a
significant effect on HEK 293 cell growth were defined
based on a Box-Behnken experimental design [3]. Three
levels of concentrations for each variable were selected
(Table 1). Using this experimental design, we were able to
define in 15 experimental runs (performed in duplicate) a
model that accurately predicts HEK 293 cell concentrations
in the presence of different concentrations of r-insulin (r-
Ins), r-transferrin (r-Trans) and lipid mix (LipMix) (Table 1).
The Box-Behnken model equation was:
Cell density (106 cells/mL) = 4,53 + 0,63 × r-Ins - 0,17
× r-Trans - 0,41 × LipMix - 0,68 × r-Ins × r-Trans +
0,02 × r-Ins × LipMix - 0,07 × rTrans × LipMix - 0,18
× r-Ins2 - 0,45 × r-Trans2 - 1,02 × LipMix2
Optimal concentrations for each supplement in HEK 293
cell culture medium were defined based on this model to be
19,8 mg/L of r-insulin, 1,6 mg/L of r-transferrin and 0,9X
for the lipid mix. These results can be inferred from
response surface graphs (Figure 1d). Finally, the model was
validated experimentally. For this purpose, the growth
kinetics of HEK 293 cells in the optimized cell culture med-
ium was analyzed. In the presence of the suitable combina-
tion/concentrations of supplements, HEK 293 cells reached
a maximum cell density of 5,4x106 cells/mL (n=3), same
value as predicted using the Box-Behnken model, as opposed
to the unsupplemented Freestyle medium that supported
cell growth up 3x106 cells/mL (n=3) (Figure 1a & 1bIII).
Conclusions
Results have shown that by adding a mixture of animal-
free supplements to serum-free culture medium, it is pos-
sible to reach high cell densities comparable to those
attained in the presence of FBS while avoiding the pro-
blems derived from its use.
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Table 1 Box-Behnken results. a Three levels of concentrations for each variable including a maximum (1), a minimum
(-1) and a center point (0) were used. Values shown in parenthesis are concentrations employed for r-transferrin and
r-insulin (mg/mL) and lipid mix (based on Synthechol® concentrations provided in X). b Cell density values presented
are mean of duplicate runs in million cells/mL.
EXP N° r-Insulina r-Transferrina Lipid Mixa Max Cell densityb
Experimental According to model
1 -1 (1) -1 (1) 0 (1) 3,1 2,8
2 1 (20) -1 (1) 0 (1) 5,5 5,4
3 -1(1) 1 (20) 0 (1) 3,7 3,8
4 1 (20) 1 (20) 0 (1) 3,3 3,7
5 -1 (1) 0 (10) -1 (0.1) 3,1 3,1
6 1 (20) 0 (10) -1 (0.1) 4,6 4,4
7 -1 (1) 0 (10) 1 (2) 2,0 2,3
8 1 (20) 0 (10) 1 (2) 3,6 3,6
9 0 (10) -1 (1) -1 (0.1) 3,2 3,6
10 0 (10) 1 (20) -1 (0.1) 3,5 3,4
11 0 (10) -1 (1) 1 (2) 2,8 2,9
12 0 (10) 1 (20) 1 (2) 2,8 2,4
13 0 (10) 0 (10) 0 (1) 4,9 4,5
13 0 (10) 0 (10) 0 (1) 4,9 4,5
13 0 (10) 0 (10) 0 (1) 3,8 4,5
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